Wealthfront Advisers
EVH icon

Wealthfront Advisers’s Evolent Health EVH Stock Holding History

Wealthfront Advisers’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Sell
20,536
-7,547
-27% -$28.9K ﹤0.01% 1089
2026
Q1 		$64K Buy
28,083
+8,136
+41% +$25.8K ﹤0.01% 1059
2025
Q4 		$79.8K Buy
+19,947
New +$111K ﹤0.01% 1040

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RPA
Rock Point Advisors Burlington, Vermont $409M AUM 30.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

Wealthfront Advisers's EVH Position: Q2 2026 in Review

Wealthfront Advisers reduced its Evolent Health (EVH) stake by 27% in Q2 2026, selling an estimated $28.9K and leaving 20,536 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1089.

Wealthfront Advisers first reported a position in EVH in Q4 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Wealthfront Advisers held 20,536 shares of Evolent Health worth $111K as of Q2 2026.
  • Wealthfront Advisers sold 7,547 Evolent Health shares in Q2 2026, an estimated $28.9K.
  • Evolent Health made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #1089 holding.
  • Wealthfront Advisers first reported a position in Evolent Health in Q4 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.